Gurmit Sandhu

Gurmit Sandhu is a leading pharmaceutical manufacturing expert dedicated to developing patient-relevant drugs during the critical Clinical Development and Market Access phases. Located in Basel, Basel Stadt 4056, CH, Gurmit Sandhu specializes in integrating patient centricity into Market Access and Clinical Development plans, particularly benefiting small to medium-sized pharmaceutical and biotech companies.

With a passion for collaboration, Gurmit Sandhu works closely with Patient Organizations, Health Economics, Outcomes Research, and Clinical Development functions, as well as HTA Agencies, to ensure effective and meaningful patient engagement. Their work addresses the growing trend of Patient Engagement in the Medicines Life Cycle, focusing on the development of drugs that are highly relevant to patients and their families. By considering patient-relevant outcomes during the Health Technology Assessment (HTA) phase, Gurmit Sandhu ensures that innovative drugs meet the needs of the patient community.

Gurmit Sandhu provides operational expertise in patient engagement activities, reducing risks and costs while ensuring high-quality, meaningful interactions for pharmaceutical companies, patient organizations, and individual patients. This includes developing Market/Patient Access Plans, Patient Advisory Boards, Steering Committees, and collaborations with Patient Groups in both high and rare diseases. We invite the management team at Gurmit Sandhu to enhance your presence on our platform with a customized and exclusive company showcase and product listing.